Israel Englander Day One Biopharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,320,095 shares of DAWN stock, worth $8.11 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,320,095
Previous 192,100
587.19%
Holding current value
$8.11 Million
Previous $2.43 Million
330.25%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DAWN
# of Institutions
198Shares Held
78.7MCall Options Held
129KPut Options Held
199K-
Atlas Venture Life Science Advisors, LLC6.43MShares$39.5 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$37.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$35.3 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$27.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$25.2 Million0.01% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $451M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...